These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28748694)

  • 1. Bilayered Nanoparticles with Sequential Release of VEGF Gene and Paclitaxel for Restenosis Inhibition in Atherosclerosis.
    Zhu X; Xie H; Liang X; Li X; Duan J; Chen Y; Yang Z; Liu C; Wang C; Zhang H; Fang Q; Sun H; Li C; Li Y; Wang C; Song C; Zeng Y; Yang J
    ACS Appl Mater Interfaces; 2017 Aug; 9(33):27522-27532. PubMed ID: 28748694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent.
    Yang J; Zeng Y; Zhang C; Chen YX; Yang Z; Li Y; Leng X; Kong D; Wei XQ; Sun HF; Song CX
    Biomaterials; 2013 Feb; 34(6):1635-43. PubMed ID: 23199742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Inhibitory Effect of the Double-layer Nano-infusion on Vascular Restenosis in Animal Models of Coronary Atherosclerosis.
    Cao G; Kang H; Yu H; He Q
    Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):314-321. PubMed ID: 35988184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery.
    Yi F; Wu H; Jia GL
    J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic nanosphere-guided site-specific delivery of vascular endothelial growth factor gene attenuates restenosis in rabbit balloon-injured artery.
    Zhang T; Qu G
    J Vasc Surg; 2016 Jan; 63(1):226-33.e1. PubMed ID: 25595406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
    Mei L; Song CX; Jin X; Che YZ; Jin Z; Sun HF
    Yao Xue Xue Bao; 2007 Jan; 42(1):81-6. PubMed ID: 17520813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of nanoparticle with vascular endothelial growth factor gene transferred into ischemic myocardium: experiment with rabbits].
    Yi F; Wu H; Jia GL; Guo WY; Lü AL; Wang HC; Zhang RQ
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):510-4. PubMed ID: 16681877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis.
    Zhu H; Kong L; Zhu X; Ran T; Ji X
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment.
    Chen Y; Zeng Y; Zhu X; Miao L; Liang X; Duan J; Li H; Tian X; Pang L; Wei Y; Yang J
    Bioact Mater; 2021 Mar; 6(3):880-889. PubMed ID: 33024904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis.
    Yang J; Zeng Y; Li Y; Song C; Zhu W; Guan H; Li X
    Eur J Pharm Sci; 2008 Dec; 35(5):427-34. PubMed ID: 18848882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.
    Xie H; Yang J; Han Y; Zhu X; Fang Q
    Exp Ther Med; 2015 Jul; 10(1):55-61. PubMed ID: 26170912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
    Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
    Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing heme with paclitaxel to prepare drug-loaded globin nanoassembles for CD163 targeting.
    Meng Z; Yang X; Hu D; Wang K; Zhi F; Chen X; Gong G; Wu J; Hu Y
    J Pharm Sci; 2015 Mar; 104(3):1045-55. PubMed ID: 25640195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.
    Dulak J; Schwarzacher SP; Zwick RH; Alber H; Millonig G; Weiss C; Hügel H; Frick M; Jozkowicz A; Pachinger O; Weidinger F
    Vasc Med; 2005 Nov; 10(4):285-91. PubMed ID: 16444857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.